ORBIMED ADVISORS LLC Insider Trading for March 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ORBIMED ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of ORBIMED ADVISORS LLC for March 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31 2021 | EWTX | Edgewise Therapeut ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 272,724 | 0 | 0 | |
| Mar 31 2021 | EWTX | Edgewise Therapeut ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 1,668,350 | 0 | 0 | |
| Mar 31 2021 | EWTX | Edgewise Therapeut ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 1,301,626 | 0 | 0 | |
| Mar 31 2021 | EWTX | Edgewise Therapeut ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 1,572,960 | 0 | 0 | |
| Mar 31 2021 | EWTX | Edgewise Therapeut ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 8,187,100 | 0 | 0 | |
| Mar 31 2021 | EWTX | Edgewise Therapeut ... | ORBIMED ADVISORS LLC | Director | Buy | P | 16.00 | 312,500 | 5,000,000 | 13,359,456 | 13 M to 13.4 M (+2.40 %) |
| Mar 31 2021 | EWTX | Edgewise Therapeut ... | ORBIMED ADVISORS LLC | Director | Buy | P | 16.00 | 46,875 | 750,000 | 319,599 | 272.7 K to 319.6 K (+17.19 %) |
| Mar 31 2021 | EWTX | Edgewise Therapeut ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 272,724 | 0 | 272,724 | 0 to 272.7 K |
| Mar 31 2021 | EWTX | Edgewise Therapeut ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 12,730,036 | 0 | 13,046,956 | 316.9 K to 13 M (+4,016.80 %) |
| Mar 31 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 23.93 | 27,869 | 666,905 | 2,212,571 | 2.2 M to 2.2 M (-1.24 %) |
| Mar 31 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 23.31 | 75,555 | 1,761,187 | 2,240,440 | 2.3 M to 2.2 M (-3.26 %) |
| Mar 26 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 23.88 | 27,816 | 664,246 | 2,315,995 | 2.3 M to 2.3 M (-1.19 %) |
| Mar 26 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 23.88 | 27,816 | 664,246 | 2,315,995 | 2.3 M to 2.3 M (-1.19 %) |
| Mar 26 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 24.70 | 51,523 | 1,272,618 | 2,343,811 | 2.4 M to 2.3 M (-2.15 %) |
| Mar 26 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 24.70 | 51,523 | 1,272,618 | 2,343,811 | 2.4 M to 2.3 M (-2.15 %) |
| Mar 26 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 24.80 | 32,959 | 817,383 | 2,395,334 | 2.4 M to 2.4 M (-1.36 %) |
| Mar 26 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 24.80 | 32,959 | 817,383 | 2,395,334 | 2.4 M to 2.4 M (-1.36 %) |
| Mar 23 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 24.32 | 3,992 | 97,085 | 2,428,293 | 2.4 M to 2.4 M (-0.16 %) |
| Mar 23 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 26.47 | 7,673 | 203,104 | 2,432,285 | 2.4 M to 2.4 M (-0.31 %) |
| Mar 23 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 26.47 | 21,275 | 563,149 | 2,439,958 | 2.5 M to 2.4 M (-0.86 %) |
| Mar 18 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 28.03 | 6,059 | 169,834 | 2,461,233 | 2.5 M to 2.5 M (-0.25 %) |
| Mar 18 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 28.43 | 18,790 | 534,200 | 2,467,292 | 2.5 M to 2.5 M (-0.76 %) |
| Mar 18 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 27.72 | 41,353 | 1,146,305 | 2,486,082 | 2.5 M to 2.5 M (-1.64 %) |
| Mar 15 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 29.14 | 89,210 | 2,599,579 | 2,527,435 | 2.6 M to 2.5 M (-3.41 %) |
| Mar 15 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 30.29 | 90,521 | 2,741,881 | 2,616,645 | 2.7 M to 2.6 M (-3.34 %) |
| Mar 15 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 33.04 | 58,551 | 1,934,525 | 2,707,166 | 2.8 M to 2.7 M (-2.12 %) |